Procedure

Exosomes Therapy in Navi Mumbai | Stem Rx IVF

Explore exosome therapy for fertility at Stem Rx IVF in Navi Mumbai. An emerging regenerative approach for ovarian health & endometrial support. Consult Dr. Pallavi Lale.

Book a Consultation

Our team will get back to you within 2 hours

What is exosome therapy for fertility, and is it available at Stem Rx IVF?

Exosome therapy is an emerging regenerative medicine approach that uses nano-sized extracellular vesicles — naturally secreted by cells — to facilitate intercellular communication and support tissue repair. At Stem Rx IVF in Navi Mumbai, exosome therapy is being explored within Fertility and Reproductive Medicine as a potential adjunct for patients with ovarian insufficiency, poor egg quality, or compromised endometrial health. It is an investigational treatment; clinical effectiveness and long-term safety have not yet been established by large-scale randomised trials.

Warning: Exosome therapy for fertility is not a standard, approved fertility treatment in India. It is offered on an investigational basis. Patients should receive a thorough consultation and informed consent before proceeding. No guarantees of improved egg quality, pregnancy, or live-birth rates can be made.

Exosomes are microscopic vesicles (typically 30–150 nm in diameter) released by virtually all cell types. They carry proteins, lipids, and genetic material — including microRNA — that influence the behaviour of recipient cells. In reproductive medicine, researchers are investigating whether exosomes derived from stem cells or other sources can signal ovarian follicles and endometrial cells to improve their function.

Who may be considered for exosome therapy at Stem Rx IVF?

Exosome therapy for fertility is currently explored for a specific subset of patients who have not responded adequately to conventional fertility treatments. Suitability is determined after a comprehensive clinical assessment by Dr. Pallavi Lale (MBBS, MD – Obstetrics & Gynaecology) at Stem Rx IVF, Navi Mumbai.

  • Diminished ovarian reserve (DOR): Low antral follicle count or elevated FSH levels suggesting reduced ovarian function.
  • Poor ovarian response: Inadequate response to standard ovarian stimulation protocols in prior IVF cycles.
  • Premature ovarian insufficiency (POI): Early decline in ovarian function before the age of 40.
  • Thin or unresponsive endometrium: Endometrial lining that fails to reach adequate thickness despite standard hormonal support, potentially affecting embryo implantation.
  • Recurrent implantation failure: Multiple failed embryo transfers despite good-quality embryos.
  • Age-related decline in egg quality: Patients of advanced maternal age exploring adjunct options alongside conventional IVF.

Note: Exosome therapy is not a replacement for established fertility treatments such as IVF or ovarian stimulation. It is considered only when conventional options have been explored or are insufficient.

How is exosome therapy performed at Stem Rx IVF?

The procedure protocol at Stem Rx IVF is individualised based on the patient's diagnosis and treatment goal. The general sequence is outlined below. Specific steps may vary following clinical evaluation.

  1. Initial consultation and assessment: Dr. Pallavi Lale reviews the patient's fertility history, hormonal profile (AMH, FSH, AFC), prior treatment records, and uterine evaluation. Informed consent covering the investigational nature of the therapy is obtained.
  2. Diagnostic workup: Baseline blood tests, transvaginal ultrasound, and where indicated, endometrial assessment are completed to confirm candidacy and establish a baseline for monitoring.
  3. Exosome preparation: Exosomes are derived from a defined cell source (the specific source used at Stem Rx IVF is confirmed at consultation). The preparation undergoes quality checks before administration.
  4. Administration: Depending on the target tissue, exosomes may be administered via intra-ovarian injection (guided by transvaginal ultrasound) or intrauterine infusion. The route is determined by the clinical indication — ovarian rejuvenation versus endometrial support.
  5. Post-procedure monitoring: The patient is observed for a short period following the procedure. Vital signs are checked and any immediate reactions are documented.
  6. Follow-up evaluation: Hormonal markers and ultrasound parameters are reassessed at defined intervals to evaluate ovarian or endometrial response before proceeding with any planned fertility treatment cycle.

What are the different approaches to exosome therapy in fertility treatment?

Exosome therapy in reproductive medicine is applied through distinct routes depending on the clinical target. The table below summarises the approaches being investigated, their intended application, and key considerations. This is an evolving field — not all approaches carry the same level of clinical evidence.

ApproachTargetIntended ApplicationEvidence Status
Intra-ovarian InjectionOvarian tissueOvarian rejuvenation; support follicular development in DOR/POIEarly-phase clinical investigation; limited human trial data
Intrauterine InfusionEndometrial liningEndometrial receptivity support; thin endometrium managementInvestigational; some pilot studies published
Systemic AdministrationSystemic / multi-tissueBroader regenerative signalling; less targetedLargely preclinical; not standard in fertility practice

For patients with thin endometrium, endometrial rejuvenation remains a more established option and may be recommended alongside or instead of exosome therapy depending on clinical findings.

What is the recovery and aftercare process following exosome therapy?

Exosome therapy for fertility is generally performed as an outpatient procedure. Recovery is typically brief, though patients are advised to follow the aftercare plan provided by their treating clinician at Stem Rx IVF.

  1. Immediately after the procedure (Day 0): Rest for 30–60 minutes at the clinic for observation. Mild pelvic discomfort or spotting may occur following intra-ovarian injection or intrauterine infusion — this is expected and usually self-limiting.
  2. First 24–48 hours: Avoid strenuous physical activity. Maintain adequate hydration. Report any unusual pain, fever, or heavy bleeding to the clinic promptly.
  3. Days 3–7: Resume normal daily activities as tolerated. Avoid intercourse unless cleared by your doctor. Continue any prescribed hormonal support medications.
  4. 2–4 weeks post-procedure: Attend the scheduled follow-up appointment. Blood tests (AMH, FSH, oestradiol) and transvaginal ultrasound are typically repeated to assess early response.
  5. 4–8 weeks post-procedure: A second evaluation determines whether ovarian or endometrial parameters have changed sufficiently to proceed with a planned fertility treatment cycle (e.g., IVF stimulation or frozen embryo transfer).
  6. Ongoing monitoring: Response to exosome therapy varies between individuals. Some patients may require more than one session. The clinical team will advise based on objective findings, not subjective response alone.

Tip: Keep a record of any symptoms between appointments and share them at your follow-up. Early data points help the clinical team adjust the treatment plan accurately.

What are the risks and limitations of exosome therapy for fertility?

Patients considering exosome therapy at Stem Rx IVF in Navi Mumbai should be fully informed of the following risks and limitations before consenting to treatment. This list is not exhaustive — a detailed discussion with Dr. Pallavi Lale is essential.

  • Unproven clinical efficacy: There is currently no large-scale, peer-reviewed randomised controlled trial confirming that exosome therapy reliably improves egg quality, ovarian reserve, or live-birth rates in humans.
  • Regulatory status in India: Exosome-based therapies are not yet approved by the Central Drugs Standard Control Organisation (CDSCO) as a standard fertility treatment. They are offered on an investigational basis.
  • Procedural risks (intra-ovarian injection): Bleeding, infection, or injury to adjacent structures are possible, as with any ultrasound-guided ovarian procedure.
  • Allergic or immune reactions: Although exosomes are generally considered low-immunogenic, reactions to the carrier medium or preparation cannot be entirely excluded.
  • Variable and unpredictable response: Not all patients respond to exosome therapy. Some may see no measurable change in ovarian or endometrial parameters.
  • Unknown long-term safety profile: Long-term data on repeated exosome administration in humans — particularly in the reproductive context — are limited.
  • Source and quality variability: The biological activity of exosomes depends heavily on their cellular source and preparation method. Standardisation across providers is not yet uniform.
  • Cost without guaranteed outcome: Exosome therapy carries a financial cost. Given the investigational nature, patients should weigh this against established alternatives.

Patients with a history of cancer, autoimmune conditions, or active pelvic infection should discuss these factors explicitly, as they may affect candidacy. For patients with structural uterine concerns, procedures such as fibroid removal or laparoscopy may need to be addressed first.

Which specialist oversees exosome therapy for fertility at Stem Rx IVF?

Exosome therapy at Stem Rx IVF in Navi Mumbai is provided under the clinical supervision of a qualified obstetrician and gynaecologist with specialist training in reproductive medicine.

DoctorQualificationsSpeciality
Dr. Pallavi LaleMBBS, MD – Obstetrics & GynaecologyFertility & Reproductive Medicine

To discuss your specific fertility history and whether exosome therapy is appropriate for your situation, use the booking form on this page or contact the clinic directly.

Stem Rx IVF is located at Ground Floor, Dr. Mahajan's Hospital & ITC, R-831, Thane–Belapur Road, Next to Shell Petrol Pump, TTC Industrial Area, Rabale, Navi Mumbai – 400708.

Book a consultation at Stem Rx IVF

Use the booking form on this page, or reach out directly:

Call: +91 19152215415

WhatsApp: +919152215433

FAQs

  • The cost of exosome therapy at Stem Rx IVF in Navi Mumbai depends on the route of administration (intra-ovarian or intrauterine), the number of sessions required, and any associated diagnostic workup. Because this is an investigational treatment, pricing is discussed during the consultation. Use the booking form on this page or WhatsApp +919152215433 for current information.
  • The key disadvantages include its unproven clinical efficacy in large human trials, lack of CDSCO approval as a standard fertility treatment in India, variable patient response, procedural risks such as bleeding or infection with intra-ovarian injection, unknown long-term safety data, and cost without a guaranteed outcome. Patients should weigh these factors carefully with their treating doctor before proceeding.
  • No. As of now, exosome-based therapies are not approved by the Central Drugs Standard Control Organisation (CDSCO) as a standard fertility treatment in India. At Stem Rx IVF, it is offered on an investigational basis following thorough patient counselling and informed consent. Patients should be aware of this regulatory status before committing to treatment.
  • Preclinical and early-phase studies suggest exosomes may support follicular signalling and cellular repair in ovarian tissue, which could theoretically influence egg quality. However, there is currently insufficient large-scale human trial data to confirm that exosome therapy reliably improves egg quality or increases pregnancy rates. No guarantees of improved egg quality or live-birth outcomes can be made.
  • Beyond procedural risks, concerns include the potential for exosomes to carry unintended biological signals — including those that could theoretically promote abnormal cell growth if derived from unhealthy source cells. Standardisation of preparation methods is also inconsistent across providers. Long-term safety in humans, particularly with repeated dosing, remains poorly characterised. These are active areas of scientific investigation.
  • Certain plant-based foods — including ginger, grapes, and some cruciferous vegetables — have been found in research to contain plant-derived exosome-like nanoparticles. However, dietary exosomes are structurally different from therapeutically prepared human or stem-cell-derived exosomes used in clinical settings. There is no evidence that consuming these foods replicates the effects of medical exosome therapy.
  • Exosome therapy uses extracellular vesicles to deliver signalling molecules to target cells such as ovarian follicles or endometrial tissue. Mitochondrial therapy focuses on supporting cellular energy production within the egg itself. Both are investigational approaches in reproductive medicine. Your doctor at Stem Rx IVF can advise which, if either, is appropriate based on your specific diagnosis. Learn more about mitochondrial therapy via the booking form.
  • The number of sessions varies by individual response and clinical indication. Some patients may be assessed after a single session before proceeding with a fertility treatment cycle, while others may require repeat administration. Follow-up hormonal and ultrasound assessments at four to eight weeks guide this decision. The treating clinician at Stem Rx IVF will advise based on objective findings.

Get Expert Guidance — Speak with a Specialist Today

Our specialists will reach out within 24 hours with personalised advice tailored to your needs.


Prefer to talk now? with our team directly.

Contact Us Today